The text starts here.

News Release

07/18/2019
EISAI PRESENTS RESEARCH EVALUATING CORRELATION OF HIGHLY-PRECISELY MEASURED AMYLOID BETA IN PLASMA AND CEREBROSPINAL FLUID WITH NEWLY DEVELOPED AUTOMATED PROTEIN ASSAY SYSTEM AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) 2019
07/18/2019
EISAI PRESENTS NONCLINICAL RESEARCH RESULTS OF ELENBECESTAT OF WITHOUT SIGNIFICANT EFFECTS ON SYNAPTIC FUNCTION IN BRAIN BY SPINAL DENSITIY EVALUATION AT EFFECTIVE DOSE TO DECREASE AMYLOID BETA LEVEL IN CEREBROSPINAL FLUID AT AAIC 2019
07/17/2019
ANTICANCER AGENT ERIBULIN MESYLATE APPROVED FOR TREATMENT OF LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN CHINA
07/11/2019
EISAI LISTED FOR 18TH CONSECUTIVE YEAR IN FTSE4GOOD INDEX SERIES, AN INDEX FOR SOCIALLY RESPONSIBLE INVESTMENT
07/10/2019
EISAI CENTER FOR GENETICS GUIDED DEMENTIA DISCOVERY COMMENCES FULL-SCALE OPERATION TOWARD INNOVATIVE DEMENTIA TREATMENTS WITH NEW DRUG DISCOVERY APPROACH IN CAMBRIDGE, MASSACHUSETTS
07/03/2019
Donate 350,000 Yuan Again to Help the Elderly with Cognitive Impairment Go Home
06/24/2019
Eisai China Supports “Health to Countryside” project for Six Consecutive Years
06/17/2019
TOTAL SYNTHESIS AND NONCLINICAL STUDY RESULTS OF A NOVEL ANTICANCER DRUG CANDIDATE E7130 DERIVED FROM TOTAL SYNTHESIS OF HALICHONDRIN FOUND IN JOINT RESEARCH BETWEEN EISAI AND HARVARD UNIVERSITY SCIENTISTS, PUBLISHED IN SCIENTIFIC REPORTS
06/14/2019
EISAI TO PRESENT LATEST DATA ON PERAMPANEL AT 33RD INTERNATIONAL EPILEPSY CONGRESS
05/29/2019
EISAI TO PRESENT LATEST DATA ON LEMBOREXANT INCLUDING INTEGRATED ANALYSIS OF PHASE III CLINICAL STUDIES AT 33RD ANNUAL SLEEP MEETING

FREESEX欧美喷水_福利区体验区120秒免费_男人的J放到女人J免费视频_无码福利在线观看1000集_亚洲欧洲国产码专区